Actively Recruiting
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance
Led by Seoul National University Hospital · Updated on 2019-02-12
410
Participants Needed
1
Research Sites
526 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, the investigators aim to establish the prostate cancer active surveillance prospective cohort in our institution, and finally investigate the 5 year rates of reclassification during active surveillance as the primary endpoint of the current study.
CONDITIONS
Official Title
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male patients younger than 80 years
- Prostate adenocarcinoma confirmed by transrectal biopsy with at least 10 cores
- Pre-biopsy PSA level of 10 ng/ml or less
- PSA density less than 0.15 ng/ml/ml
- Clinical stage T1 to T2a prostate cancer
- Biopsy Gleason score of 6 or less
- Two or fewer positive biopsy cores
- Maximum cancer involvement of 20% or less in any one core
- No PIRADS 5 lesion on multiparametric prostate MRI (1.5T or 3T)
- Willingness to attend follow-up visits; confirmation of T1a-b disease by systematic biopsy with at least 10 cores
You will not qualify if you...
- Previous therapy for prostate cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 110-744
Actively Recruiting
Research Team
M
Min Ji Seo, Bachelor
CONTACT
C
Chang Wook Jeong, M.D, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here